These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 16256870)

  • 1. Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine.
    Thum T; Tsikas D; Stein S; Schultheiss M; Eigenthaler M; Anker SD; Poole-Wilson PA; Ertl G; Bauersachs J
    J Am Coll Cardiol; 2005 Nov; 46(9):1693-701. PubMed ID: 16256870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension.
    Diller GP; van Eijl S; Okonko DO; Howard LS; Ali O; Thum T; Wort SJ; Bédard E; Gibbs JS; Bauersachs J; Hobbs AJ; Wilkins MR; Gatzoulis MA; Wharton J
    Circulation; 2008 Jun; 117(23):3020-30. PubMed ID: 18519847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
    Böger RH; Bode-Böger SM; Sydow K; Heistad DD; Lentz SR
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability.
    Huang PH; Chen YH; Tsai HY; Chen JS; Wu TC; Lin FY; Sata M; Chen JW; Lin SJ
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):869-77. PubMed ID: 20093623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: Effect of combination with oral L-arginine.
    Böger GI; Rudolph TK; Maas R; Schwedhelm E; Dumbadze E; Bierend A; Benndorf RA; Böger RH
    J Am Coll Cardiol; 2007 Jun; 49(23):2274-82. PubMed ID: 17560293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis.
    Weis M; Kledal TN; Lin KY; Panchal SN; Gao SZ; Valantine HA; Mocarski ES; Cooke JP
    Circulation; 2004 Feb; 109(4):500-5. PubMed ID: 14732750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial progenitor cell mobilization and increased intravascular nitric oxide in patients undergoing cardiac rehabilitation.
    Paul JD; Powell TM; Thompson M; Benjamin M; Rodrigo M; Carlow A; Annavajjhala V; Shiva S; Dejam A; Gladwin MT; McCoy JP; Zalos G; Press B; Murphy M; Hill JM; Csako G; Waclawiw MA; Cannon RO
    J Cardiopulm Rehabil Prev; 2007; 27(2):65-73. PubMed ID: 17558240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric dimethylarginine endogenous inhibition of nitric oxide synthase causes differential vasculature effects.
    Cable DG; Celotto AC; Evora PR; Schaff HV
    Med Sci Monit; 2009 Sep; 15(9):BR248-53. PubMed ID: 19721392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats.
    De Gennaro Colonna V; Bonomo S; Ferrario P; Bianchi M; Berti M; Guazzi M; Manfredi B; Muller EE; Berti F; Rossoni G
    Eur J Pharmacol; 2007 Feb; 557(2-3):178-85. PubMed ID: 17258196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased (E)-4-hydroxy-2-nonenal and asymmetric dimethylarginine concentrations and decreased nitric oxide concentrations in the plasma of patients with major depression.
    Selley ML
    J Affect Disord; 2004 Jun; 80(2-3):249-56. PubMed ID: 15207938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors.
    Urbich C; Dimmeler S
    Kidney Int; 2005 May; 67(5):1672-6. PubMed ID: 15840010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase.
    Hsu CP; Zhao JF; Lin SJ; Shyue SK; Guo BC; Lu TM; Lee TS
    J Am Heart Assoc; 2016 Apr; 5(4):e003327. PubMed ID: 27091343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.
    Selcuk MT; Selcuk H; Temizhan A; Maden O; Ulupinar H; Baysal E; Ozeke O; Sasmaz A
    Coron Artery Dis; 2007 Nov; 18(7):545-51. PubMed ID: 17925608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X.
    Chen JW; Hsu NW; Wu TC; Lin SJ; Chang MS
    Am J Cardiol; 2002 Nov; 90(9):974-82. PubMed ID: 12398965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans.
    Chan JR; Böger RH; Bode-Böger SM; Tangphao O; Tsao PS; Blaschke TF; Cooke JP
    Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):1040-6. PubMed ID: 10764670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress.
    Suda O; Tsutsui M; Morishita T; Tasaki H; Ueno S; Nakata S; Tsujimoto T; Toyohira Y; Hayashida Y; Sasaguri Y; Ueta Y; Nakashima Y; Yanagihara N
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1682-8. PubMed ID: 15217805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible involvement of crosstalk between advanced glycation end products (AGEs) and asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor in accelerated atherosclerosis in diabetes.
    Yamagishi S; Ueda S; Okuda S
    Med Hypotheses; 2007; 69(4):922-4. PubMed ID: 17368960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia.
    Maas R; Quitzau K; Schwedhelm E; Spieker L; Rafflenbeul W; Steenpass A; Lüscher TF; Böger RH
    Atherosclerosis; 2007 Mar; 191(1):211-9. PubMed ID: 16828780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin stimulates an endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine, in experimental heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Wang X; Kinoshita M
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():241S-244S. PubMed ID: 12193095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric dimethylarginine and nitric oxide levels as signs of endothelial dysfunction in Behcet's disease.
    Sahin M; Arslan C; Naziroglu M; Tunc SE; Demirci M; Sutcu R; Yilmaz N
    Ann Clin Lab Sci; 2006; 36(4):449-54. PubMed ID: 17127734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.